The landscape of multiple myeloma treatment has undergone a profound transformation with the advent of monoclonal antibodies (mAbs) targeting CD38. Among the notable breakthroughs, two anti-CD38 mA...
In recent years, the rapid development of technology and innovation has sped up the transformation of the healthcare and well-being industry. Among the various emerging and evolving trends, Light Therapy is one of the key technologies gaining immense attention among the users. Light Therapy is an ancient practice, ...
Find More
Step aside, CAR-Ts; with three FDA approvals, the class of bispecific antibodies has begun to take on the relapsed/refractory multiple myeloma treatment segment. Currently, the US Food and Drug Administration (FDA) has authorized 10 bispecific antibodies and one bispecific molecule, the majority of which are a...
Find More
Homozygous familial hypercholesterolemia (HoFH) is a rare form of familial hypercholesterolemia, an autosomal-dominant genetic disorder of lipid metabolism characterized by strikingly elevated levels of low-density lipoprotein cholesterol (LDL-C). Heterozygous Familial Hypercholesterolemia vs. Homozygous F...
Find More
Contact lenses have emerged as a groundbreaking innovation within the realm of vision correction, fundamentally reshaping how individuals perceive the world. Serving as an alternative to conventional eyeglasses, contact lenses hold significant value by not only improving visual clarity, but also delivering a natura...
Find More
In a bittersweet decision for Biogen and Sage Therapeutics, the FDA approved the fast-acting drug zuranolone as the first tablet for postpartum depression on 04 August —but rejected the drug for major depressive disorder treatment. Zurzuvae is a neuroactive steroid that acts as a GABA-A receptor-positive allosteric...
Find More
Globally, more than 5 million people are affected by geographic atrophy. Also, as per the published study by the GER group, the global prevalence of geographic atrophy is 0.66% in all ages, but it occurs in 0.34% for 65–74 years old, 1.3% for 75–84, and 4.4% over 85 years old. Geographic atrophy is a progressive, i...
Find More
Snoring, a common sleep-related issue, can disrupt both the snorer's sleep and that of their partner or roommate. As per the estimate, about 90 million Americans suffer from snoring, either temporarily or semi-permanently, due to colds, allergies, or other factors. Snoring can have several implications, and it can ...
Find More
Chronic urticarial is a common skin condition characterized by itchy, wheal-and-flare skin reactions or hives. As per Delveinsight analysts, in 2022, there were around 776K individuals in the US affected by chronic urticaria. It can be spontaneous or inducible, lasting more than 6 weeks and persisting for over a ye...
Find More
Multiple myeloma is the second most prevalent blood cancer diagnosis in the United States, after non-Hodgkin lymphoma. Males are significantly more likely than females to have multiple myeloma. Myeloma incidence is highly tied to age, with older adults having the highest incidence rates and being diagnosed most fre...
Find More
An autoimmune disease in which the immune system attacks its healthy skin, Cutaneous Lupus Erythemat.....
Find More
The Union of the European countries, also known as the European Union or the EU, is more or less lik.....
Find More
Nestlé and Unilever are multinational corporations established in 1866 and 1930, respectively. The .....
Find More
Primary Progressive Aphasia (PPA) is a rare neurological disorder that results from the damages to t.....
Find More
Affecting the entire body, Adult Onset Still's disease (AOSD) is a rare type of inflammatory arthrit.....
Find More
T cell Lymphoma (TCL) is cancer that develops in the T-lymphocytes. T-cell Lymphomas are majorly cla.....
Find More-Agonist.png "Toll-like Receptors Agonist")
The American Society of Clinical Oncology (ASCO) is one of the largest and most respected conferences in the field of oncology. Held annually, this conference brings together researchers, physicians, and other healthcare professionals from around the world to discuss the latest advances in cancer research, diagnosis, and treatment.
